Speaker illustration

Doctor Javid Moslehi

UCSF Medical Centre, San Francisco (United States of America)

Dr. Moslehi is the William Grossman Distinguished Professor in Cardiology and Chief, Section of Cardio-Oncology, Immunology and Metabolism at UCSF. Dr. Moslehi also directs a basic research laboratory, with general focus on mechanisms of cardiovascular signaling. He graduated from Johns Hopkins University and University of Connecticut School of Medicine. After completing an internal medicine residency at Johns Hopkins Hospital and clinical cardiology fellowship at the Brigham and Women's Hospital and Harvard Medical School, he started a basic science post-doctoral fellowship at the Dana-Farber Cancer Institute. In 2009, he founded the Cardio-Oncology program at Brigham and Women's Hospital/Dana-Farber Cancer Institute and Harvard Medical School before being recruited to Vanderbilt to direct cardio-oncology in 2014. In 2021, he was recruited to UCSF. He has established a fellowship training the next generation of physician-scientists in the cardio-oncology.

Check-point inhibition: cardiovascular consequences and their prevention

Event: ESC Congress 2024

Topic: Leukocytes, Inflammation, Immunity

Session: Therapeutic modulation of the immune system in cardiovascular diseases

Thumbnail

Immune checkpoint inhibition and cardiovascular toxicity

Event: ESC Congress 2023

Topic: Basic Science

Session: Translational insights from cardioimmunology for human heart failure

Thumbnail

Shared mechanisms in heart failure and cancer.

Event: ESC Congress 2020

Topic: Cardio-Oncology

Session: Cardio-oncology in Focus

Thumbnail

Cardiomyopathy development following breast cancer treatment: restratification.

Event: ESC Congress 2020

Topic: Basic Science, Other

Session: Mechanisms of Chemotherapy-Induced Cardiotoxicity

Thumbnail

Can we prevent toxicity of immune checkpoint inhibitors?

Event: ESC Congress 2020

Topic: Basic Science

Session: Cardio-Oncology: More Than Cardiotoxicity

Thumbnail

A patient with cancer, arrhythmias and heart failure: optimal clinical approach?

Event: Heart Failure 2020

Topic: Chronic Heart Failure, Other

Session: HFA Focus: challenging clinical scenarios in heart failure

Thumbnail

Immunotherapy: between hope and hype?

Event: Heart Failure 2020

Topic: Cardio-Oncology

Session: Cardio-oncology: linking the heart and cancer

Thumbnail

Challenges in the long-term follow-up of cardio-oncology patients.

Event: ESC Congress 2019

Topic: Cardio-Oncology

Session: Cardiovascular health in cancer patients and survivors

Thumbnail

Cardiovascular toxicity associated with immune checkpoint inhibitors.

Event: ESC Congress 2019

Topic: Cardio-Oncology

Session: Cardio-oncology: what every cardiologist should know about cardiovascular effects of cancer treatment

Thumbnail

Cardiovascular side effects of anti-tumor drugs.

Event: ESC Congress 2019

Topic: Basic Science, Other

Session: Cardio-Oncology: Novel mechanisms and clinical implications

Thumbnail